CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects

L Zhu; RJ Bruggemann; J Uy; A Colbers; MW Hruska; E Chung; K Sims; B Vakkalagadda; XH (XiaoHui) Xu; Ron van Schaik; DM Burger; RJ Bertz

doi:10.1002/jcph.798

CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects

L Zhu, RJ Bruggemann, J Uy, A Colbers, MW Hruska, E Chung, K Sims, B Vakkalagadda, XH (XiaoHui) Xu, Ron van Schaik, DM Burger, RJ Bertz

Clinical Chemistry

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	235-246
Number of pages	12
Journal	Journal of Clinical Pharmacology
Volume	57
Issue number	2
DOIs	https://doi.org/10.1002/jcph.798
Publication status	Published - 2017

Access to Document

10.1002/jcph.798

http://hdl.handle.net/1765/108604

Cite this

Zhu, L., Bruggemann, RJ., Uy, J., Colbers, A., Hruska, MW., Chung, E., Sims, K., Vakkalagadda, B., Xu, XH., van Schaik, R., Burger, DM., & Bertz, RJ. (2017). CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects. Journal of Clinical Pharmacology, 57(2), 235-246. https://doi.org/10.1002/jcph.798

Zhu, L ; Bruggemann, RJ ; Uy, J ; Colbers, A ; Hruska, MW ; Chung, E ; Sims, K ; Vakkalagadda, B ; Xu, XH (XiaoHui) ; van Schaik, Ron ; Burger, DM ; Bertz, RJ. / CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects. In: Journal of Clinical Pharmacology. 2017 ; Vol. 57, No. 2. pp. 235-246.

@article{41f8b03933144d8db03e6cee4ef410ce,

title = "CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects",

author = "L Zhu and RJ Bruggemann and J Uy and A Colbers and MW Hruska and E Chung and K Sims and B Vakkalagadda and Xu, {XH (XiaoHui)} and {van Schaik}, Ron and DM Burger and RJ Bertz",

year = "2017",

doi = "10.1002/jcph.798",

language = "Undefined/Unknown",

volume = "57",

pages = "235--246",

journal = "Journal of Clinical Pharmacology",

issn = "0091-2700",

publisher = "Wiley-Blackwell",

number = "2",

}

Zhu, L, Bruggemann, RJ, Uy, J, Colbers, A, Hruska, MW, Chung, E, Sims, K, Vakkalagadda, B, Xu, XH, van Schaik, R, Burger, DM & Bertz, RJ 2017, 'CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects', Journal of Clinical Pharmacology, vol. 57, no. 2, pp. 235-246. https://doi.org/10.1002/jcph.798

CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects. / Zhu, L; Bruggemann, RJ; Uy, J; Colbers, A; Hruska, MW; Chung, E; Sims, K; Vakkalagadda, B; Xu, XH (XiaoHui); van Schaik, Ron; Burger, DM; Bertz, RJ.

In: Journal of Clinical Pharmacology, Vol. 57, No. 2, 2017, p. 235-246.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects

AU - Zhu, L

AU - Bruggemann, RJ

AU - Uy, J

AU - Colbers, A

AU - Hruska, MW

AU - Chung, E

AU - Sims, K

AU - Vakkalagadda, B

AU - Xu, XH (XiaoHui)

AU - van Schaik, Ron

AU - Burger, DM

AU - Bertz, RJ

PY - 2017

Y1 - 2017

U2 - 10.1002/jcph.798

DO - 10.1002/jcph.798

M3 - Article

VL - 57

SP - 235

EP - 246

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 2

ER -